Content area

|
|

Succesfuld behandling af akut promyelocytleukæmi uden brug af kemoterapi og blodtransfusion

Forfatter(e)
Michael Tøstesen, Lene S.G. Østgård, Eigil Kjeldsen, Jesper Stentoft & Jan M. Nørgaard Hæmatologisk Afdeling, Aarhus Universitetshospital Ugeskr Læger 2018;180:V06170489
Reference: 
Ugeskr Læger 2018;180:V06170489
Blad nummer: 
Sidetal: 
2-3
Successful treatment of acute promyelocytic leukaemia without chemotherapy and blood transfusion
Untreated acute promyelocytic leukaemia (APL) is a rapidly lethal blood cancer. Conventional treatment consists of all-trans retinoic acid and chemotherapy. Standard chemo­therapy-containing treatments necessitate the use of blood products. This is a case report of typical APL in a 32-year-old female patient, who due to religious conviction refused supportive therapy with blood products. A treatment regimen consisting of all-trans retinoic acid and arsenic trioxide was successful without the use of blood transfusions.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Frede Simonsen | 20/04
2 kommentarer
af Hans Storm Erichsen | 19/04
1 Kommentar
af Debatred. | 15/04
1 Kommentar
af Martin Bonde Petersen | 15/04
1 Kommentar
af Anne Lisbeth Hoffmann | 15/04
4 kommentarer
af Jørgen Lous | 13/04
9 kommentarer
af Karin Marlen Moldrup | 13/04
3 kommentarer